Rhumbline Advisers Lantheus Holdings, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 209,537 shares of LNTH stock, worth $19 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
209,537
Previous 217,175 3.52%
Holding current value
$19 Million
Previous $17.4 Million 31.89%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$77.7 - $123.62 $593,472 - $944,209
-7,638 Reduced 3.52%
209,537 $23 Million
Q2 2024

Aug 01, 2024
BUY
$58.87 - $83.05 $216,288 - $305,125
3,674 Added 1.72%
217,175 $17.4 Million
Q1 2024

May 09, 2024
BUY
$51.07 - $68.26 $42,030 - $56,177
823 Added 0.39%
213,501 $13.3 Million
Q4 2023

Feb 08, 2024
SELL
$55.6 - $77.89 $251,312 - $352,062
-4,520 Reduced 2.08%
212,678 $13.2 Million
Q3 2023

Nov 09, 2023
BUY
$60.27 - $90.75 $44,057 - $66,338
731 Added 0.34%
217,198 $15.1 Million
Q2 2023

Aug 08, 2023
SELL
$82.41 - $99.65 $55,049 - $66,566
-668 Reduced 0.31%
216,467 $18.2 Million
Q1 2023

May 11, 2023
BUY
$47.76 - $82.86 $117,346 - $203,587
2,457 Added 1.14%
217,135 $17.9 Million
Q4 2022

Feb 14, 2023
BUY
$48.76 - $77.67 $1.13 Million - $1.81 Million
23,246 Added 12.14%
214,678 $10.9 Million
Q3 2022

Nov 10, 2022
BUY
$61.42 - $86.29 $650,990 - $914,587
10,599 Added 5.86%
191,432 $13.5 Million
Q2 2022

Aug 11, 2022
SELL
$55.54 - $72.65 $189,780 - $248,245
-3,417 Reduced 1.85%
180,833 $11.9 Million
Q1 2022

May 12, 2022
SELL
$24.28 - $56.64 $31,175 - $72,725
-1,284 Reduced 0.69%
184,250 $10.2 Million
Q4 2021

Feb 10, 2022
SELL
$22.54 - $30.44 $158,298 - $213,780
-7,023 Reduced 3.65%
185,534 $5.36 Million
Q3 2021

Nov 12, 2021
SELL
$24.23 - $28.59 $607,785 - $717,151
-25,084 Reduced 11.53%
192,557 $4.95 Million
Q2 2021

Aug 05, 2021
BUY
$19.51 - $27.64 $283,694 - $401,913
14,541 Added 7.16%
217,641 $6.02 Million
Q1 2021

May 06, 2021
SELL
$13.77 - $21.66 $1,018 - $1,602
-74 Reduced 0.04%
203,100 $4.34 Million
Q4 2020

Feb 10, 2021
BUY
$10.75 - $14.91 $185,867 - $257,793
17,290 Added 9.3%
203,174 $2.74 Million
Q3 2020

Nov 12, 2020
SELL
$11.98 - $16.34 $376,986 - $514,187
-31,468 Reduced 14.48%
185,884 $2.36 Million
Q2 2020

Aug 13, 2020
BUY
$10.34 - $15.51 $964,329 - $1.45 Million
93,262 Added 75.16%
217,352 $3.11 Million
Q1 2020

May 06, 2020
BUY
$9.11 - $20.05 $22,674 - $49,904
2,489 Added 2.05%
124,090 $1.58 Million
Q4 2019

Feb 05, 2020
BUY
$18.47 - $24.03 $121,865 - $158,549
6,598 Added 5.74%
121,601 $2.49 Million
Q3 2019

Oct 23, 2019
BUY
$21.01 - $28.94 $46,411 - $63,928
2,209 Added 1.96%
115,003 $2.88 Million
Q2 2019

Aug 14, 2019
BUY
$23.33 - $28.3 $128,454 - $155,819
5,506 Added 5.13%
112,794 $3.19 Million
Q1 2019

May 01, 2019
BUY
$14.93 - $25.1 $16,378 - $27,534
1,097 Added 1.03%
107,288 $2.63 Million
Q4 2018

Jan 31, 2019
BUY
$12.68 - $19.01 $242,048 - $362,881
19,089 Added 21.92%
106,191 $1.66 Million
Q3 2018

Nov 07, 2018
BUY
$13.1 - $16.35 $115,568 - $144,239
8,822 Added 11.27%
87,102 $1.3 Million
Q2 2018

Aug 06, 2018
BUY
$13.65 - $18.7 $120,393 - $164,934
8,820 Added 12.7%
78,280 $1.14 Million
Q1 2018

May 02, 2018
BUY
$14.85 - $24.3 $45,723 - $74,819
3,079 Added 4.64%
69,460 $1.1 Million
Q4 2017

Feb 09, 2018
BUY
$17.4 - $23.4 $220,614 - $296,688
12,679 Added 23.61%
66,381 $1.36 Million
Q3 2017

Nov 06, 2017
BUY
$15.5 - $19.15 $832,381 - $1.03 Million
53,702
53,702 $956,000

Others Institutions Holding LNTH

# of Institutions
540
Shares Held
68.3M
Call Options Held
679K
Put Options Held
423K
View Full List

About Lantheus Holdings, Inc.

LNTH Quotes by TradingView
  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.22B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email